BridgeMD
New treatment option for HIV
Official title We-INtervention Among Chinese HIV-serodiscordant Male Couples
ClinicalTrials.gov ID: NCT06639932
What this study is testing
- What it's testing
- HIV-serodiscordant male couples, in which one male partner is HIV-seropositive and the other is HIV-seronegative, experience multiple risks in HIV care and prevention. As stigma often hinders such couples' access to support and services, leveraging their relational resources is crucial for optimizing their outcomes.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only. Healthy volunteers may be eligible.
You may be able to join if
- both partners are male,
- both partners are aged 18 or above,
- both partners report being in a committed relationship for at least 3 months,
- one partner is HIV-seropositive and the other partner is HIV-seronegative (i.e., serodiscordant couple),
- both partners have disclosed their serostatus to each other, and
You likely can't join if
- either partner is unable to complete the assessment due to a low education level or to physical or psychological constraints and
- either partner has been diagnosed with another chronic disease (e.g., cancer and coronary heart disease).
See the full eligibility criteria
- both partners are male,
- both partners are aged 18 or above,
- both partners report being in a committed relationship for at least 3 months,
- one partner is HIV-seropositive and the other partner is HIV-seronegative (i.e., serodiscordant couple),
- both partners have disclosed their serostatus to each other, and
- both partners are willing to participate in this study.
- either partner is unable to complete the assessment due to a low education level or to physical or psychological constraints and
- either partner has been diagnosed with another chronic disease (e.g., cancer and coronary heart disease).
The study team makes the final eligibility decision.
Where it's taking place
- Xiamen, Fujian, China
- Guangzhou, Guangdong, China
- Shenzhen, Guangdong, China
- Chengdu, Sichuan, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Xiamen, Fujian, China; Guangzhou, Guangdong, China; Shenzhen, Guangdong, China; Chengdu, Sichuan, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.